Context Therapeutics (CNTX) Other Non Operating Income (2020 - 2026)

Context Therapeutics has disclosed Other Non Operating Income across 5 years of filings, most recently posting $143088.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $143088.0, up 2256.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $350194.0 (up 3167.57% YoY), and the FY2025 annual result was $200471.0, up 14138.59% from the prior year.
• Other Non Operating Income came in at $143088.0 for Q1 2026 at Context Therapeutics, up from $96555.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $143088.0 in Q1 2026 to a low of -$6635.0 in Q1 2025.
• The 3-year median for Other Non Operating Income is $3478.0 (2024), against an average of $38014.6.
• Peak annual rise in Other Non Operating Income reached 3978.76% in 2025, while the deepest fall reached 297.88% in 2025.
• Context Therapeutics' Other Non Operating Income stood at $3478.0 in 2024, then jumped by 2676.16% to $96555.0 in 2025, then jumped by 48.19% to $143088.0 in 2026.
• The last three Other Non Operating Income figures came in at $143088.0 (Q1 2026), $96555.0 (Q4 2025), and $83471.0 (Q3 2025), per Business Quant data.